Tolvaptan alleviates excessive fluid retention of nephrotic diabetic renal failure unresponsive to furosemide.
Sign Up to like & getrecommendations! Published in 2018 at "Nephrology"
DOI: 10.1111/nep.13286
Abstract: Patients with diabetic nephropathy develop nephrotic syndrome, and may show limited response to conventional therapy. They often require earlier initiation of renal replacement therapy because they become refractory to diuretics, and experience excessive fluid retention.… read more here.
Keywords: failure; diabetic renal; excessive fluid; fluid retention ... See more keywords